MissionIR Articles

Gulf Resources, Inc. (NASDAQ: GURE) operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and ShouguangYuxin Chemical Industry Co., Limited (“SYCI”). The company believes that it is one of the largest producers…

Great Panther Silver Ltd. (NYSE: GPL) is a primary silver mining and exploration company whose current activities are focused on the mining of precious metals from its two whollyowned mining operations in Mexico: the Guanajuato…

GeoVax Labs, Inc. (OTC: GOVX) is a clinical-stage biotechnology company developing innovative human vaccines using its novel VLP (virus-like particle) platform technology. The company’s proprietary vaccine technology has been developed through multi-year collaborations with the…

GenSpera, Inc. (OTC: GNSZ) is a biotechnology company focused on the development and commercialization of promising, new therapeutics. GenSpera combines powerful insights and rigorous scientific methods to create new treatment options for patients. The company’s…

U.S.-based General Moly, Inc. (NYSE: GMO) is a mineral company engaged in the exploration, development and mining of molybdenum (”moly”). The company owns two world-class moly projects located in Nevada, U.S.; an 80% interest in…

Galena Biopharma, Inc. (NASDAQ: GALE) is developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets,…

Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular…

Georgia-based Galectin Therapeutics, Inc. (NASDAQ: GALT) is a biotechnology company focused on discovery and development. The company applies its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer.…

Fusion Telecommunications International, Inc. (NASDAQ: FSNN),in concert with its subsidiaries, provides cloud communications, cloud connectivity, cloud computing, and managed cloud-based solutions to small, medium, and large businesses worldwide. The company also offers voice services to…

Global Blood Therapeutics, Inc. (NASDAQ: GBT) is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its initial product…

FlexShopper, Inc. (OTC: FPAY) provides a flexible and easy way for consumer to get furniture, electronics, appliances and other popular brand name goods through low, affordable weekly payments. The company’s goal is to get customers…

The biotechnology company Flex Pharma, Inc. (NASDAQ: FLKS) is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions. Flex Pharma’s products will be designed to…

Finjan Holdings, Inc. (NASDAQ: FNJN) offers investors a diversified and unique vehicle for investing in cybersecurity-related intellectual property-backed technologies under the guidance of a proven team. Finjan’s commitment to innovation in the security space continues…

Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases. The company is primarily focused on developing programmed hematopoietic cellular…

Eyegate Pharmaceuticals, Inc. (OTC: EYEG), a late-stage specialty pharmaceutical and drug delivery company, is working on developing and commercializing therapeutics and drug delivery mechanisms for treating eye diseases. The company’s technology addresses two of the…

EuroSite Power, Inc. (OTC: EUSP) is a majority-owned subsidiary of American DG Energy, and has been established to expand its successful on-site utility business into the United Kingdom and Europe. The company sells the energy…

Energy Fuels, Inc. (NYSE: UUUU) is America’s premier integrated uranium miner. Uranium is the fuel for nuclear, which is the true “green energy” as it provides emission-free and carbon-free electricity. Energy Fuels is positioned as…

Emisphere Technologies, Inc. (EMIS) is a specialty pharmaceutical company that recently commenced commercial operations. The company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the company…

Emisphere Technologies, Inc. (OTCBB: EMIS), a commercial stage, specialty pharmaceutical company, is currently preparing to launch its first prescription product, oral Eligen B12, in the United States. Beyond Eligen B12, the company employs its proprietary…

eMagin Corporation (NYSE: EMAN) is a leading manufacturer of active-matrix Organic LED (AM-OLED) microdisplays on silicon. These displays perform at low-power levels, extended temperature ranges and provide image performance not possible with LCD technologies. The…

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is a specialty pharmaceutical companydeveloping a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers…

Echo Therapeutics, Inc. (NASDAQ: ECTE) is changing the blood glucose monitoring industry. The company has successfully demonstrated the ability to continuously monitor blood glucose non-invasively in healthy, Type I, Type II and hospital patients. Echo’s…

Biopharmaceutical company DURECT Corporation (NASDAQ: DRRX) has expertise in drug discovery, delivery and development, applying those skills primarily to therapeutics in the fields of pain management, CNS disorders, acute organ injury and metabolic diseases. The…

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) is a late stage pharmaceutical company focused on developing and selling Locilex (pexiganan cream 0.8%), a potent and broad spectrum topical antibiotic peptide, for the treatment of mild and moderate…

DiaMedica, Inc. (OTCQB: DMCAF) is a biopharmaceutical company focused on developing innovative treatments for stroke and other vascular diseases where no current therapies are available. The company is preparing to advance its proprietary recombinant form…

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) is a clinical and commercial stage drug development company with a focus on the treatment of cancer. The company is in the midst of conducting clinical trials in the U.S.…

Delcath Systems, Inc. (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and, more specifically, the treatment of primary and metastatic liver cancers. The company’s proprietary product – Melphalan Hydrochloride for…

DBV Technologies S.A. (NASDAQ: DBVT) is committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. The company has a proprietary platform…

DARA BioSciences, Inc. (NASDAQ: DARA) is an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising…

CytRx Corporation (NASDAQ: CYTR) is a biopharmaceutical research and development company specializing in oncology. CytRx is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic…

CytoSorbents Corp. (NASDAQ: CTSO) is a critical care immunotherapy company using blood purification to treat life-threatening illnesses. The company has developed a new hemoperfusion technology for removing toxins from the blood associated with sepsis, kidney…

CytoDyn, Inc. (OTCQB: CYDY) is focused on developing new therapies that provide flexibility and freedom to people across the globe who are living with HIV. The company’s lead product, PRO 140, belongs to a new…

Cynapsus Therapeutics, Inc. (NASDAQ: CYNA)  is a specialty central nervous system pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, sublingual thin film for the on-demand turning ON of debilitating OFF episodes associated with…

Cymabay Therapeutics, Inc. (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan…

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a…

Critical Outcome Technologies, Inc. (OTC: COTQF) is engaged in disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small…

Cortex Pharmaceuticals, Inc. (OTC: CORX) has multiple drug development programs targeted toward the treatment of brain-related breathing disorders, such as obstructive or central sleep apnea and drug-induced respiratory depression. One key program involves the development…

CorMedix, Inc. (NYSE: CRMD) is a commercial-stage biopharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix’s first commercial product in Europe…

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) operates as a biopharmaceutical company focused on developing targeted antiviral therapies. The company has two drug candidates in clinical studies. The first, FV-100, is now in phase III trials and…

CombiMatrix Corp. (NASDAQ: CBMX) is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard…